The Short-term Rise and Fall of Bristol-Myers Squibb Co (BMY) Stock

Currently, Bristol-Myers Squibb Co [BMY] is trading at $57.88, up 3.67%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BMY shares have gain 7.38% over the last week, with a monthly amount drifted -2.13%, and not seem to be holding up well […]

Bristol-Myers Squibb’s [NYSE: BMY] Breyanzi Receives FDA Approval

Bristol-Myers Squibb [NYSE: BMY] declared that FDA has awarded permission to the Breyanzi of the firm for the therapy of adult sufferers with relapsed or refractory large B-cell lymphoma. Breyazni is a CAR T cell Therapy. This therapy is a ray of hope for the victims experiencing relapsed or refractory large B-cell lymphoma. The authorization […]